Compliance with 118216 is not just a technical requirement; it is a critical safety measure. Sterile barrier systems must withstand more than just the passage of time; they must remain intact after the physical stresses of sterilization, shipping, and handling. If a seal fails or a material becomes brittle, the device can become contaminated, posing a lethal risk to patients. Therefore, the aging process is followed by a battery of tests, including bubble emission tests, seal strength tests, and microbial challenge studies, to prove the barrier remains uncompromised.
Furthermore, 118216 requires a dual-track validation process. While accelerated aging provides the data necessary for a product launch, manufacturers are simultaneously required to conduct real-time aging studies. These real-time tests serve as the ultimate confirmation of the accelerated results, ensuring that the theoretical calculations hold up under actual storage conditions. This layered approach reflects the medical industry’s "safety-first" philosophy, where no margin for error is permitted. 118216
At its core, the standard relies on the Arrhenius reaction rate theory. This principle states that for every ten-degree Celsius increase in temperature, the rate of chemical reaction roughly doubles. In the context of medical packaging, this means that exposing a sterile barrier system to elevated temperatures—typically between 50°C and 60°C—accelerates the natural degradation of materials like Tyvek, medical-grade films, and adhesives. By calculating an "Accelerated Aging Factor," engineers can determine exactly how long a package must stay in an oven to simulate a specific period of real-time aging, such as two or five years. Compliance with 118216 is not just a technical